Paul J Orchard – Projects and Grants — Experts@Minnesota

View Scopus Profile

Emailorcha001umnedu

Research activity per year

If you made any changes in Pure these will be visible here soon.

10 Active
24 Finished

10 results

Filter

Active
A Phase I Open Label Study to Evaluate the Safety andTolerability of ISP-001 in Patients with MucopolysaccharidosisType I
Orchard, P. J.
IMMUSOFT CORPORATION
12/9/21 → 1/1/26
Project: Research project
Lysosomal Storage Disease Focused Training
Orchard, P. J. & Miller, B. S.
SANOFI-AVENTIS US
11/8/21 → 11/7/23
Project: Research project
Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial, with Cross-Over, of Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transpl
Orchard, P. J.
ALLOVIR, INC
10/25/21 → 10/31/26
Project: Research project
An Open Label, Prospective, Historically controlled, Nonrandomized Clinical Study of OTL-200 for the Treatment of Patients with Early Symptoms of Early Juvenile (EJ) Metachromatic Leukodystrophy (MLD)
Orchard, P. J.
ORCHARD THERAPEUTICS
12/1/20 → 11/25/25
Project: Research project
Engineered B Cells as a Universal Platform for the Treatment of Enzymopathies
Moriarity, B. S., Lund, T. C., McIvor, R. S., Orchard, P. J. & Webber, B. R.
NIH Nat'l Inst of Allergy & Infect Dis
3/1/20 → 2/28/25
Project: Research project
Lysosomal Disease Network
Whitley, C. B., Ahmed, A., Braunlin, E. A., Cortez, D., Eisengart, J., King, K. E., Nestrasil, I. & Orchard, P. J.
NIH NAT INST OF NEURO DISORDERS & STROKE
9/15/19 → 7/31/25
Project: Research project
IMD-002: A FOLLOW-UP STUDY TO EVALUATE THE SAFETY AND CLINICAL OUTCOMES OF PATIENTS WITH NON-MALIGNANT DISEASES WHO HAVE UNDERGONE HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH MGTA-456
Orchard, P. J.
MAGENTA THERAPEUTICS
7/1/19 → 6/30/24
Project: Research project
Longterm Follow-up of Subjects With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product
Orchard, P. J.
Bluebird Bio, Inc.
7/1/19 → 6/30/24
Project: Research project
A Phase 3 Study of Lenti-D Drug Product After Myeloablative Conditioning Using Busulfan and Fludarabine in Subjects ≤ 17 Years of Age With Cerebral Adrenoleukodystrophy (CALD)
Orchard, P. J., Gupta, A. O., Kenney-Jung, D. L. & Lund, T. C.
Bluebird Bio, Inc.
2/1/19 → 1/31/24
Project: Research project
Pre-Clinical Study Sleeping Beauty Transposon-Engineered
Orchard, P. J.
IMMUSOFT CORPORATION
4/28/17 → 12/31/26
Project: Research project